Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.
2.

Risk management plans as a tool for proactive pharmacovigilance: a cohort study of newly approved drugs in Europe.

Vermeer NS, Duijnhoven RG, Straus SM, Mantel-Teeuwisse AK, Arlett PR, Egberts AC, Leufkens HG, De Bruin ML.

Clin Pharmacol Ther. 2014 Dec;96(6):723-31. doi: 10.1038/clpt.2014.184. Epub 2014 Sep 15.

PMID:
25222619
3.

Compliance in European pharmacovigilance: a regulatory view.

Arlett PR, Harrison P.

Pharmacoepidemiol Drug Saf. 2001 Jun-Jul;10(4):301-2. No abstract available.

PMID:
11760490
4.

Reporting adverse drug reactions in HIV infection.

Arlett PR, Lee EH, Hooker M, Darbyshire JH, Breckenridge AM.

Genitourin Med. 1997 Oct;73(5):335. No abstract available.

5.

A case of laboratory acquired brucellosis.

Arlett PR.

BMJ. 1996 Nov 2;313(7065):1130-2. No abstract available. Erratum in: BMJ 1997 Jan 11;314(7074):134.

6.

The psychological care of medical patients.

Arlett PR.

J R Coll Physicians Lond. 1995 Sep-Oct;29(5):447-8. No abstract available.

Supplemental Content

Loading ...
Support Center